Filing Details

Accession Number:
0001225208-16-033173
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-11 18:04:56
Reporting Period:
2016-05-10
Filing Date:
2016-05-11
Accepted Time:
2016-05-11 18:04:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1551792 D John Young Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Group President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-10 41,700 $25.87 200,399 No 4 M Direct
Common Stock Disposition 2016-05-10 400 $33.54 199,999 No 4 S Direct
Common Stock Disposition 2016-05-10 500 $33.57 199,499 No 4 S Direct
Common Stock Disposition 2016-05-10 700 $33.55 198,799 No 4 S Direct
Common Stock Disposition 2016-05-10 782 $33.50 198,017 No 4 S Direct
Common Stock Disposition 2016-05-10 1,400 $33.56 196,617 No 4 S Direct
Common Stock Disposition 2016-05-10 1,475 $33.49 195,142 No 4 S Direct
Common Stock Disposition 2016-05-10 4,525 $33.58 190,617 No 4 S Direct
Common Stock Disposition 2016-05-10 14,800 $33.52 175,817 No 4 S Direct
Common Stock Disposition 2016-05-10 17,118 $33.53 158,699 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-05-10 41,700 $0.00 41,700 $25.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-02-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,306 Indirect By Rule 16b-3 Plan
Common Stock 1,348 Indirect By Trustee under the Pfizer Share Ownership Plan
Footnotes
  1. These options are fully exercisable.